By combining state-of-the-art research techniques with an unconventional clinical sampling strategy, we exposed and validated tumor-associated CD8+ T cells in the CB of newly diagnosed, treatment-naive glioblastoma. The gene discussed is CD8A; the disease is glioblastoma.